Mahoney Michael F
- SEC CIK
- 0001533022
In the past year, 1 open-market purchase filing worth $9.00M and 1 sale filing worth $15.0M.
Current role at each company
- BSX Boston Scientific CorpChairman, President & CEOas of Aug 5, 2026
- CVS CVS Health CorpDirectoras of May 15, 2026
- BAX Baxter International IncDirectoras of May 4, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $9.00M
- 1 filing
- Sold
- $15.0M
- 1 filing
- Net
- −$6.04M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Mahoney Michael F as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BSX Boston Scientific Corp
Chairman, President & CEO20 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2021 (view filing) | Jul 6 | 2 days | Mahoney Michael FChairman, President & CEO | SSale | −201.0K | $43.41 | −$8.73M | −8.8%2.08M after | |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Mahoney Michael FChairman, President & CEO | SSale | −201.0K | $45.74 | −$9.20M | −8.8%2.08M after | |
| Sep 8, 2021 (view filing) | Sep 7 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −201.0K | $44.57 | −$8.96M | −8.8%2.08M after | |
| Oct 5, 2021 (view filing) | Oct 4 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −201.0K | $42.92 | −$8.63M | −8.8%2.08M after | 2 lots |
| Nov 2, 2021 (view filing) | Nov 1 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −201.0K | $43.05 | −$8.65M | −8.8%2.08M after | |
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −125.8K | $40.97 | −$5.16M | −5.6%2.13M after | |
| Sep 7, 2022 (view filing) | Sep 6 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −125.8K | $40.49 | −$5.09M | −6.6%1.77M after | |
| Oct 4, 2022 (view filing) | Oct 3 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −125.8K | $39.34 | −$4.95M | −6.6%1.77M after | |
| Nov 8, 2022 (view filing) | Nov 7 | 1 day | Mahoney Michael FChairman, President & CEO | SSale | −125.8K | $41.97 | −$5.28M | −6.6%1.77M after | |
| Sep 12, 2023 (view filing) | Sep 12 | Same day | Mahoney Michael FChairman, President & CEO | SSale | −113.4K | $53.91 | −$6.11M | −7.0%1.50M after |
CVS CVS Health Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 2, 2024 (view filing) | May 2 | Same day | Mahoney Michael FDirector | PPurchaseCommon Stock (By Trust) | +9.18K | $54.49 | +$500.3K | +5,246.3%9.36K after | |
| Feb 19, 2025 (view filing) | Feb 18 | 1 day | Mahoney Michael FDirector | PPurchaseCommon Stock (By Trust) | +30.0K | $66.70 | +$2.00M | +320.6%39.4K after |